Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Glioma
Related studies linked through entity extraction aliases.
Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
- Status
- WITHDRAWN
- Phase
- PHASE1
BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
- Status
- COMPLETED
- Phase
- N/A
Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)
- Status
- COMPLETED
- Phase
- N/A
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Establishment of a Brain and Spinal Tumor Tissue Bank
- Status
- UNKNOWN
- Phase
- N/A
A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma
- Status
- UNKNOWN
- Phase
- PHASE2
Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
- Status
- UNKNOWN
- Phase
- N/A
Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed)
- Status
- COMPLETED
- Phase
- PHASE2
Gliogene: Brain Tumor Linkage Study
- Status
- UNKNOWN
- Phase
- N/A
Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
- Status
- COMPLETED
- Phase
- PHASE2